| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2849868 | American Heart Journal | 2008 | 9 Pages |
Abstract
In addition to its reported rhythm-targeting and rate-targeting therapeutic actions in paroxysmal and persistent AF, dronedarone improves ventricular rate control in patients with permanent AF. Dronedarone was well tolerated with no evidence of organ toxicities or proarrhythmias in this short-term study.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jean-Marc MD, PhD, Martin MD, Christer MD, Alphons MD, Antonio MD, PhD, David MD, Louis MD, PhD, for the ERATO Study Investigators for the ERATO Study Investigators,